Get started
Author

Andrea Rattaro

Observed name: A. Rattaro
ORCID: 0000-0003-3119-4568
Observed ORCID: 0000-0003-3119-4568
OpenAlex ID: A5090879321
The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review
2023 · Giulia Ferrarazzo, Alberto Nieri, et al. · Current Oncology · 20
PDF
Residual Prolapse in Patients with III-IV Degree Haemorrhoids Undergoing Stapled Haemorrhoidopexy with CPH34 HV: Results of an Italian Multicentric Clinical Study
2014 · Giuliano Reboa, Marco Gipponi, et al. · Surgery Research and Practice · 4
PDF
“No ink on Ductal Carcinoma in situ? ” A single Center experience”
2019 · P. Fregatti, M. Gipponi, et al. · European Journal of Surgical Oncology · 1
Time-restricted eating and metformin (TEAM) in invasive breast cancer or DCIS: A randomized, phase IIb, window-of-opportunity presurgical trial.
2026 · Parijatham S. Thomas, Stefano Spinaci, et al. · Journal of Clinical Oncology
Main findings of robotic nipple-sparing mastectomy: An umbrella review
2026 · S. Spinaci, A. Rattaro, et al. · European Journal of Cancer
Treatments of interest in male breast cancer: An umbrella review
2026 · S. Spinaci, A. Rattaro, et al. · European Journal of Cancer
Data from Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis
2026 · Irene Maria Briata, Stefano Spinaci, et al.
Supplementary Table 1 from Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis
2026 · Irene Maria Briata, Stefano Spinaci, et al.
Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis
2025 · Irene Maria Briata, Stefano Spinaci, et al. · Cancer Prevention Research
PDF
Works count: 9
Citation count: 25
H-index: 2
I10-index: 1
Year
Topic
Type